logo

Bio-Path Holdings Inc (BPTH)



Trade BPTH now with
  Date
  Headline
3/11/2022 7:10:26 AM Bio-Path Holdings FY Net Loss $10.4 Mln Or $1.55/Shr Vs Loss Of $10.9 Mln Or $2.83/Shr Last Year
8/24/2021 7:13:42 AM Bio-Path: FDA Clears IND Application For BP1002 In R/r Acute Myeloid Leukemia Patients
6/22/2021 7:21:17 AM Bio-Path Holdings Says USPTO Granted New Patent Relating To BP1003 Program
5/14/2021 7:05:41 AM Bio-Path Holdings Q1 Loss/Shr $0.43 Vs Loss $0.90 Prior Year